These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34290702)

  • 1. Antibody Subclass and Glycosylation Shift Following Effective TB Treatment.
    Grace PS; Dolatshahi S; Lu LL; Cain A; Palmieri F; Petrone L; Fortune SM; Ottenhoff THM; Lauffenburger DA; Goletti D; Joosten SA; Alter G
    Front Immunol; 2021; 12():679973. PubMed ID: 34290702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role for Antibodies in Tuberculosis.
    Lu LL; Chung AW; Rosebrock TR; Ghebremichael M; Yu WH; Grace PS; Schoen MK; Tafesse F; Martin C; Leung V; Mahan AE; Sips M; Kumar MP; Tedesco J; Robinson H; Tkachenko E; Draghi M; Freedberg KJ; Streeck H; Suscovich TJ; Lauffenburger DA; Restrepo BI; Day C; Fortune SM; Alter G
    Cell; 2016 Oct; 167(2):433-443.e14. PubMed ID: 27667685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclasses' response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection.
    de Araujo LS; da Silva NBM; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2018 Jan; 108():70-76. PubMed ID: 29523330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease.
    Kumar SK; Arya S; Aggarwal A; Kapoor P; Nath A; Misra R; Sinha S
    PLoS One; 2020; 15(1):e0228359. PubMed ID: 32004357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
    Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
    Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.
    Achkar JM; Prados-Rosales R
    Curr Opin Immunol; 2018 Aug; 53():30-37. PubMed ID: 29656063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.
    Maekura R; Kitada S; Osada-Oka M; Tateishi Y; Ozeki Y; Fujicawa T; Miki M; Jyunnko O; Mori M; Matsumoto S
    Microbiol Immunol; 2019 Mar; 63(3-4):130-138. PubMed ID: 30851131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
    Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
    Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
    Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
    Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
    Lu LL; Das J; Grace PS; Fortune SM; Restrepo BI; Alter G
    J Infect Dis; 2020 Nov; 222(12):2093-2102. PubMed ID: 32060529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigens of
    Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
    Front Immunol; 2020; 11():582414. PubMed ID: 33117393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB.
    Awoniyi DO; Baumann R; Chegou NN; Kriel B; Jacobs R; Kidd M; Loxton AG; Kaempfer S; Singh M; Walzl G
    Oncotarget; 2017 Jun; 8(23):37525-37537. PubMed ID: 28415587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG glycosylation associates with risk of progression from latent to active tuberculosis.
    Burel JG; Wang W; Wuhrer M; Dedicoat M; Fletcher TE; Cunningham AF; O'Shea MK
    J Infect; 2024 Mar; 88(3):106115. PubMed ID: 38309308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of
    Hjelmar KJS; de Armas LR; Goldberg E; Pallikkuth S; Mathad J; Montepiedra G; Gupta A; Pahwa S
    Front Immunol; 2024; 15():1423435. PubMed ID: 38994354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.